Key Highlights

High-purity lyophilized peptide
Third-party tested by a Reputable USA Laboratory (COA available)
Secure, sealed vial for stability
Ships from USA
Research-grade quality standards

Tesamorelin – Research Peptide

Tesamorelin is a synthetic peptide studied for its interaction with growth hormone–releasing hormone (GHRH) receptor pathways in controlled laboratory environments.

It is a stabilized analog of naturally occurring GHRH, designed to interact with signaling pathways involved in growth hormone regulation and downstream metabolic processes.

Reconstitution Guidance

For improved consistency and ease of handling, 3 mL of bacteriostatic water is recommended for reconstitution of this product to fully dissolve and avoid gelling issues.

General Reconstitution Steps

Allow vial contents to reach room temperature before reconstitution.
Using a sterile syringe, slowly add 3 mL of bacteriostatic water down the inside wall of the vial.
Do not inject directly onto the lyophilized cake.
Gently swirl until fully dissolved.
Do not shake vigorously.
Store reconstituted material under refrigerated conditions.

Note: Reconstitution guidance is provided solely for product handling and storage consistency. Researchers are responsible for determining appropriate research protocols and concentrations for their specific applications.

Why This Compound Stands Out

Tesamorelin is a modified analog of GHRH, engineered for increased stability and receptor interaction in research settings.

Its targeted interaction with GHRH pathways makes it distinct from broader-acting compounds, allowing for more specific study of growth hormone–related signaling and downstream biological responses.

Research Overview

In controlled laboratory environments, Tesamorelin is commonly examined for:

GHRH receptor binding and activation
Growth hormone signaling pathways
Downstream metabolic and endocrine responses
Hormone-related regulatory mechanisms

Its structure and mechanism allow researchers to study signaling pathways associated with growth hormone activity in a more controlled and targeted way.